A quantitative measure of treatment response in recent‐onset type 1 diabetes

por Bundy, Brian N., Krischer, Jeffrey P.
Publicado 2020

The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes

por Bingley, Polly J., Boulware, David C., Krischer, Jeffrey P.
Publicado 2015

Feature ranking based on synergy networks to identify prognostic markers in DPT-1

por Adl, Amin Ahmadi, Qian, Xiaoning, Xu, Ping, Vehik, Kendra, Krischer, Jeffrey P
Publicado 2013

Distribution of C-Peptide and Its Determinants in North American Children at Risk for Type 1 Diabetes

por Xu, Ping, Qian, Xiaoning, Schatz, Desmond A., Cuthbertson, David, Krischer, Jeffrey P.
Publicado 2014

Long-Term Outcome of Individuals Treated With Oral Insulin: Diabetes Prevention Trial–Type 1 (DPT-1) oral insulin trial

por Vehik, Kendra, Cuthbertson, David, Ruhlig, Holly, Schatz, Desmond A., Peakman, Mark, Krischer, Jeffrey P.
Publicado 2011

Prognostic Accuracy of Immunologic and Metabolic Markers for Type 1 Diabetes in a High-Risk Population: Receiver operating characteristic analysis

por Xu, Ping, Beam, Craig A., Cuthbertson, David, Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P.
Publicado 2012

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Palmer, Jerry P., Rafkin-Mervis, Lisa, Krischer, Jeffrey P., Cuthbertson, David, Matheson, Della, Skyler, Jay S.
Publicado 2008

The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network

por Merkel, Peter A., Manion, Michele, Gopal-Srivastava, Rashmi, Groft, Stephen, Jinnah, H. A., Robertson, David, Krischer, Jeffrey P.
Publicado 2016

Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes

por Xu, Ping, Wu, Yougui, Zhu, Yiliang, Dagne, Getachew, Johnson, Giffe, Cuthbertson, David, Krischer, Jeffrey P., Sosenko, Jay M., Skyler, Jay S.
Publicado 2010

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood

por Vehik, Kendra, Haller, Michael J., Beam, Craig A., Schatz, Desmond A., Wherrett, Diane K., Sosenko, Jay M., Krischer, Jeffrey P.
Publicado 2011

SARS-CoV-2 — No Increased Islet Autoimmunity or Type 1 Diabetes in Teens

por Krischer, Jeffrey P., Lernmark, Åke, Hagopian, William A., Rewers, Marian J., McIndoe, Richard, Toppari, Jorma, Ziegler, Anette-Gabriele, Akolkar, Beena
Publicado 2023

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

por Sosenko, Jay M., Palmer, Jerry P., Rafkin, Lisa E., Krischer, Jeffrey P., Cuthbertson, David, Greenbaum, Carla J., Eisenbarth, George, Skyler, Jay S.
Publicado 2010

Development of Autoantibodies in the TrialNet Natural History Study

por Vehik, Kendra, Beam, Craig A., Mahon, Jeffrey L., Schatz, Desmond A., Haller, Michael J., Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P.
Publicado 2011

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants

por Sosenko, Jay M., Skyler, Jay S., Palmer, Jerry P., Krischer, Jeffrey P., Cuthbertson, David, Yu, Liping, Schatz, Desmond A., Orban, Tihamer, Eisenbarth, George
Publicado 2011

A novel approach to conducting clinical trials in the community setting: utilizing patient-driven platforms and social media to drive web-based patient recruitment

por Applequist, Janelle, Burroughs, Cristina, Ramirez, Artemio, Merkel, Peter A., Rothenberg, Marc E., Trapnell, Bruce, Desnick, Robert J., Sahin, Mustafa, Krischer, Jeffrey P.
Publicado 2020

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

por Orban, Tihamer, Sosenko, Jay M., Cuthbertson, David, Krischer, Jeffrey P., Skyler, Jay S., Jackson, Richard, Yu, Liping, Palmer, Jerry P., Schatz, Desmond, Eisenbarth, George
Publicado 2009

The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Repo...

por Krischer, Jeffrey P., Liu, Xiang, Lernmark, Åke, Hagopian, William A., Rewers, Marian J., She, Jin-Xiong, Toppari, Jorma, Ziegler, Anette-G., Akolkar, Beena
Publicado 2017

Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pil...

por Tosi, Laura L., Floor, Marianne K., Dollar, Christina M., Gillies, Austin P., Hart, Tracy S., Cuthbertson, David D., Sutton, V. Reid, Krischer, Jeffrey P.
Publicado 2019

Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone

por Micheletti, Robert G., Pagnoux, Christian, Tamura, Roy N., Grayson, Peter C., McAlear, Carol A., Borchin, Renee, Krischer, Jeffrey P., Merkel, Peter A.
Publicado 2020

Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Palmer, Jerry P., Rafkin-Mervis, Lisa, Krischer, Jeffrey P., Cuthbertson, David, Mahon, Jeffery, Greenbaum, Carla J., Cowie, Catherine C., Skyler, Jay S.
Publicado 2009